Vessel Sealing Devices Market Is Estimated To Expand Further At A CAGR Of 8.1% By 2028

Comments · 503 Views

The global vessel sealing devices market size was valued at USD 1.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028.

Vessel Sealing Devices Industry Overview

The global vessel sealing devices market size was valued at USD 1.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028.

Growing product developments, surgical procedures, and preference for minimally invasive surgeries are some of the key drivers of this market. Medtronic, a market leader in vessel sealing devices for example, registered record sales of USD 5.4 million in its surgical innovations portfolio comprising of advanced energy, stapling, and visualization devices. This was owing to a strong portfolio with continuous product enhancements.

Gather more insights about the market drivers, restrains and growth of the Global Vessel Sealing Devices Market

Rising product improvements is a key driver contributing to the growth of the market for vessel sealing devices. This is due to the growing demand for vessel sealing devices that offer better consistency, utility, reliability, efficiency, and safety. According to an article published in the International Journal of Scientific Research, an ideal vessel sealing device is effective on vessels having a diameter less than or equal to 7mm, produces minimal thermal spread, works quickly, is reusable, and produces consistent results. Market players are also involved in integrating these devices into robotic surgical systems. For example, Intuitive Surgical’s SynchroSeal is compatible with the da Vinci surgical system and enables the user to quickly seal and cut vessels up to 5 mm in diameter.

Elective surgeries are anticipated to return to pre-COVID numbers as the underlying causes remain unchanged. The American Society of Anesthesiologists (ASA) has released several guidelines for resuming elective surgery. The American College of Surgeons has also released a roadmap for resuming elective surgeries in collaboration with the ASA, Association of Perioperative Registered Nurses, and the American Hospital Association. There is also a growing preference for minimally invasive surgeries due to associated benefits such as smaller incisions, reduced pain and scarring, and faster recovery times. These factors are estimated to contribute to the growth of the market for vessel sealing devices during the forecast period. 

The COVID-19 pandemic adversely impacted the market for vessel sealing devices with low demand and sales. This resulted from supply chain challenges, deferred or canceled elective procedures, reduced sales and marketing activities, and movement restrictions due to lockdowns. Medtronic for instance reported a negative impact of COVID-19 on its fourth-quarter financial results ending April 24, 2020. The company was also impacted by the postponed elective and semi-elective procedures that use Medtronic’s products. The reluctance of people for undergoing non-COVID-19 emergency procedures affected the company’s emergent product lines.

In its 2020 annual report, Intuitive Surgical reported a 3.0% decrease in revenue compared to 2019, owing to constraints in staff and ICU capacity in hospitals and deferred surgical procedures. The company reported a 19.0% year-on-year decline in procedures during Q2 2020 with a gradual recovery in Q3 and Q4. Intuitive Surgical estimated that about 1.25 million surgeries were performed during the year. The company, however, reported growth in its surgical energy portfolio, with its E-100 generator, SynchroSeal system, and vessel sealers lineup gaining customer acceptance. The company planned to expand its regional presence outside the U.S., advance its product launches, and extend economic, clinical, and hospital-by-hospital validation in key countries and procedures, as part of its 2021 strategy.

Browse through Grand View Research's Medical Devices Industry Research Reports

  • Biosimilar Contract Manufacturing Market: The global biosimilar contract manufacturing market size was valued at USD 5.3 billion in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 18.5% over the forecast period. 
  • Kidney Stone Retrieval Devices Market: The global kidney stone retrieval devices market size was valued at USD 2.66 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.7% from 2022 to 2030. 

Vessel Sealing Devices Market Segmentation

Grand View Research has segmented the global vessel sealing devices market on the basis of application, product, end user, and region:

Vessel Sealing Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

  • General Surgery
  • Laparoscopic Surgery

Vessel Sealing Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Generators
  • Instruments
  • Accessories

Vessel Sealing Devices End-user Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals Specialty Clinics
  • Ambulatory Surgical Centers

Vessel Sealing Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA 

Market Share Insights

  • January 2021: Bolder Surgical launched CoolSeal Vessel Sealing Platform thus adding to its line of vessel sealing products.
  • November 2019: Intuitive Surgical’s SynchroSeal vessel sealer and E-100 Generator for da Vinci X/Xi surgical platforms received FDA clearance. 

Key Companies profiled:

Some of the prominent players in the vessel sealing devices market include:  

  • Medtronic
  • Olympus Corporation
  • B. Braun Melsungen AG
  • Medical Devices Business Services, Inc. (Johnson Johnson)
  • Erbe Elektromedizin GmbH
  • Bowa Medical
  • OmniGuide Holdings, Inc.
  • Intuitive Surgical
  • Bolder Surgical, LLC
  • KLS Martin Group 

Order a free sample PDF of the Vessel Sealing Devices Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter 

Comments